Bone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationTransplantation, AutologousGraft vs Host DiseaseBone MarrowBone Marrow CellsTransplantation ConditioningTissue DonorsGraft SurvivalStem Cell TransplantationStem CellsWhole-Body IrradiationHematologic NeoplasmsKidney TransplantationLeukemiaHistocompatibility TestingBusulfanHematopoietic Stem CellsTreatment OutcomeRecurrenceTransplantation ChimeraAnemia, AplasticImmunosuppressive AgentsGraft RejectionHistocompatibilityTransplantationBone and BonesTime FactorsCombined Modality TherapyRetrospective StudiesLeukemia, Myeloid, AcuteRemission InductionBone Marrow PurgingCytomegalovirus InfectionsGraft vs Tumor EffectHeart TransplantationSurvival AnalysisCyclophosphamideTransplantation, IsogeneicTransplantsLiver TransplantationImmunosuppressionPeripheral Blood Stem Cell TransplantationImmunocompromised HostLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLung TransplantationSurvival RateTransplantation ImmunologyMice, Inbred C57BLHematopoiesisCyclosporineHepatic Veno-Occlusive DiseaseGranulocyte Colony-Stimulating FactorPrecursor Cell Lymphoblastic Leukemia-LymphomaAcute DiseaseOpportunistic InfectionsT-LymphocytesDisease-Free SurvivalCell DifferentiationLymphocyte DepletionHLA AntigensBone Marrow DiseasesHematologic DiseasesRadiation ChimeraLeukocyte TransfusionLymphoma, Non-HodgkinFollow-Up StudiesMultiple MyelomaLeukemia, MyeloidHematopoietic Stem Cell MobilizationAntineoplastic Combined Chemotherapy ProtocolsMyelodysplastic SyndromesGraft vs Host ReactionGraft vs Leukemia EffectEmbryonic Stem CellsCells, CulturedFatal OutcomePostoperative ComplicationsMelphalanAntigens, CD34Flow CytometryBone Marrow ExaminationCord Blood Stem Cell TransplantationCytomegalovirusAdult Stem CellsMycosesColony-Forming Units AssayMesenchymal Stem Cell TransplantationAspergillosisLiving DonorsChimeraCell TransplantationBone RemodelingSalvage TherapyPrognosisBone Marrow NeoplasmsTacrolimusChimerismProspective Studies